EVMN Operating Cash Flow (Statement)

Evommune, Inc. Common Stock · Operating Cash Flow (Statement)

EVMN logo

EVMN Operating Cash Flow (Statement)

Latest reported-$74.15M
EVMN TTM Cash from Operations (-$58.20M → -$74.15M)
High-resolution chart · PNG

EVMN operating cash flow (statement) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Evommune, Inc. Common Stock Operating Cash Flow (Statement) — Trailing twelve months (TTM) (USD)
Period endingOperating Cash Flow (Statement) (USD)
-74,153,000
-80,045,000
-76,441,000
-78,254,000
-94,846,000
-77,264,000
-58,195,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.